Skip to main content
. 2015 Nov 25;10(11):e0143755. doi: 10.1371/journal.pone.0143755

Fig 10. Interaction of mutant TP53 and microRNA signaling pathways in chemoresistant pancreatic cancer.

Fig 10

Target analysis was performed by Ingenuity Pathway Analysis and DIANA-mirPath.